These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6707383)

  • 1. Electrophysiologic basis for the suppression by amiodarone of orthodromic supraventricular tachycardias complicating pre-excitation syndromes.
    Feld GK; Nademanee K; Weiss J; Stevenson W; Singh BN
    J Am Coll Cardiol; 1984 May; 3(5):1298-307. PubMed ID: 6707383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Wolff-Parkinson-White syndrome with orthodromic supraventricular tachycardia associated with a "hyper-conductor" atrio-ventricular node. A therapeutic challenge].
    Hernández González D; Iturralde Torres P; Romero L; Colín L; Villarreal A; González Hermosillo JA
    Arch Inst Cardiol Mex; 1990; 60(2):175-81. PubMed ID: 2378538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Electrophysiologic effects of amiodarone in Wolf-Parkinson-White syndrome].
    Touboul P; Porte J; Huerta F; Delahaye JP
    Arch Mal Coeur Vaiss; 1976 Aug; 69(8):855-63. PubMed ID: 823923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic effects of amiodarone in patients with refractory ventricular tachycardia.
    Saksena S; Rothbart ST; Cappello G
    Int J Cardiol; 1983 Jun; 3(3):339-52. PubMed ID: 6347914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of amiodarone in paroxysmal supraventricular tachycardia with or without Wolff-Parkinson-White syndrome.
    Wellens HJ; Brugada P; Abdollah H
    Am Heart J; 1983 Oct; 106(4 Pt 2):876-80. PubMed ID: 6613833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy and electrophysiologic effects of intravenous and oral encainide in patients with accessory atrioventricular pathways and supraventricular arrhythmias.
    Abdollah H; Brugada P; Green M; Wehr M; Wellens HJ
    Am J Cardiol; 1984 Sep; 54(6):544-9. PubMed ID: 6433688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of amiodarone studied by programmed electrical stimulation of the heart in patients with paroxysmal re-entrant supraventricular tachycardia.
    Waleffe A; Bruninx P; Kulbertus HE
    J Electrocardiol; 1978 Jul; 11(3):253-60. PubMed ID: 308527
    [No Abstract]   [Full Text] [Related]  

  • 8. Electrophysiologic effects and clinical efficacy of flecainide in children with recurrent paroxysmal supraventricular tachycardia.
    Musto B; D'Onofrio A; Cavallaro C; Musto A; Greco R
    Am J Cardiol; 1988 Aug; 62(4):229-33. PubMed ID: 3135739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of amiodarone in the Wolff-Parkinson-White syndrome.
    Wellens HJ; Lie KI; Bär FW; Wesdorp JC; Dohmen HJ; Düren DR; Durrer D
    Am J Cardiol; 1976 Aug; 38(2):189-94. PubMed ID: 952262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the electrophysiologic effects of intravenous and oral amiodarone in the same patient.
    Wellens HJ; Brugada P; Abdollah H; Dassen WR
    Circulation; 1984 Jan; 69(1):120-4. PubMed ID: 6689635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and electrophysiologic effects of amiodarone in patients with atrial fibrillation complicating the Wolff-Parkinson-White syndrome.
    Feld GK; Nademanee K; Stevenson W; Weiss J; Klitzner T; Singh BN
    Am Heart J; 1988 Jan; 115(1 Pt 1):102-7. PubMed ID: 3336964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia.
    Gambhir DS; Bhargava M; Nair M; Arora R; Khalilullah M
    Indian Heart J; 1996; 48(2):133-7. PubMed ID: 8682552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sotalol in supraventricular tachycardia. Electrophysiologic measurements in Wolff-Parkinson-White syndrome and AV node re-entry tachycardia].
    Manz M; Kuhl AJ; Lüderitz B
    Z Kardiol; 1985 Sep; 74(9):500-5. PubMed ID: 4060827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of propafenone in the Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up.
    Breithardt G; Borggrefe M; Wiebringhaus E; Seipel L
    Am J Cardiol; 1984 Nov; 54(9):29D-39D. PubMed ID: 6496367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of amiodarone on supraventricular tachycardia involving bypass tracts.
    Alboni P; Shantha N; Pirani R; Baggioni F; Scarfo S; Tomasi AM; Masoni A
    Am J Cardiol; 1984 Jan; 53(1):93-8. PubMed ID: 6691283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias.
    Rowland E; Krikler DM
    Br Heart J; 1980 Jul; 44(1):82-90. PubMed ID: 7426165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of amiodarone in the Wolff-Parkinson-White syndrome with rapid ventricular response via accessory pathway during atrial fibrillation.
    Kappenberger LJ; Fromer MA; Steinbrunn W; Shenasa M
    Am J Cardiol; 1984 Aug; 54(3):330-5. PubMed ID: 6465013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of oral amiodarone on rate-dependent changes in refractoriness in patients with Wolff-Parkinson-White syndrome.
    Brugada P; Wellens HJ
    Am J Cardiol; 1985 Nov; 56(13):863-6. PubMed ID: 4061328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of amiodarone in the Wolff-Parkinson-White syndrome. A clinical and electrophysiological study.
    Rasmussen V; Berning J
    Acta Med Scand; 1979; 205(1-2):31-7. PubMed ID: 367085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of programmed stimulation in predicting efficacy of propafenone in long-term antiarrhythmic therapy for paroxysmal supraventricular tachycardia.
    Manz M; Steinbeck G; Lüderitz B
    Am J Cardiol; 1985 Oct; 56(10):593-7. PubMed ID: 4050693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.